Literature DB >> 894032

Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.

A T Sobel, A I Branellec, C J Blanc, G A Lagrue.   

Abstract

Stimulation of human lymphocytes with Con A resulted in the liberation of a soluble lymphokine that increased the permeability of guinea pig skin capillaries. This factor, termed vascular permeability factor (VPF), was characterized by physicochemical methods. Upon gel filtration chromatography on Sephadex G-100, it eluted in a narrow peak with an apparent molecular weight of 12,000 daltons. The sedimentation rate of VPF, estimated by sucrose density gradient ultracentrifugation, was 1.8 S. Polyacrylamide gel electrophoresis showed the biologic activity to migrate in the beta region; the factor displayed a pI of 6.4 upon isoelectric focusing. These characteristics allow VPF to be distinguished from other human lymphokines.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894032

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

2.  Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood.

Authors:  S Toyabe; U Kaneko; M Hara; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 3.  The role of lymphokines in delayed-type hypersensitivity reactions.

Authors:  C L Geczy
Journal:  Springer Semin Immunopathol       Date:  1984

Review 4.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

5.  Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome.

Authors:  W E Smoyer; A Gupta; P Mundel; J D Ballew; M J Welsh
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Phase I trial of FK973: description of a delayed vascular leak syndrome.

Authors:  R Pazdur; D H Ho; K Daugherty; W T Bradner; I H Krakoff; M N Raber
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

7.  Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome.

Authors:  C Y Lin
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

8.  Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome.

Authors:  J M Heslan; A I Branellec; Y Pilatte; P Lang; G Lagrue
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice.

Authors:  R K Puri; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 10.  Immunologic mechanisms of parenchymal lung injury.

Authors:  W F Willoughby; J B Willoughby
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.